Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$80.59 - $92.61 $18,777 - $21,578
233 New
233 $19,000
Q2 2021

Aug 03, 2021

SELL
$51.81 - $118.56 $1.65 Million - $3.79 Million
-31,929 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$111.01 - $139.48 $2.99 Million - $3.76 Million
-26,927 Reduced 45.75%
31,929 $3.57 Million
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $63,988 - $86,483
721 Added 1.24%
58,856 $6.99 Million
Q3 2020

Nov 13, 2020

BUY
$75.65 - $93.58 $1.87 Million - $2.31 Million
24,694 Added 73.84%
58,135 $5.07 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $706,442 - $988,736
8,315 Added 33.09%
33,441 $3 Million
Q1 2020

May 14, 2020

BUY
$74.34 - $121.82 $1.87 Million - $3.06 Million
25,126 New
25,126 $2.5 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.2B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.